Related Experiment Videos

Characterization of thymosin-responsive peripheral blood null cells.

Cancer Treatment Reports
|November 1, 1978
PubMed
Summary

Thymosin (a peptide hormone) activates specific human peripheral blood null cells to form E rosettes. These thymosin-responsive cells are precommitted to the T-cell differentiation pathway, indicating a role for thymosin in T-cell development.

Related Concept Videos